Sherbrooke Park Advisers LLC Inogen Inc Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Inogen Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 27,683 shares of INGN stock, worth $274,338. This represents 0.08% of its overall portfolio holdings.
Number of Shares
27,683
Previous 59,069
53.13%
Holding current value
$274,338
Previous $573 Million
55.7%
% of portfolio
0.08%
Previous 0.13%
Shares
3 transactions
Others Institutions Holding INGN
# of Institutions
145Shares Held
20.9MCall Options Held
88.5KPut Options Held
116K-
Camber Capital Management LP Boston, MA2MShares$19.8 Million0.42% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$16.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.46MShares$14.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.36MShares$13.5 Million0.3% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN849KShares$8.41 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $227M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...